Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir

J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):127-9. doi: 10.1097/QAI.0b013e318157b0da.
No abstract available

MeSH terms

  • Atazanavir Sulfate
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Oligopeptides / administration & dosage
  • Oligopeptides / therapeutic use*
  • Pyridines / administration & dosage
  • Pyridines / therapeutic use*
  • Ritonavir / administration & dosage
  • Ritonavir / therapeutic use*
  • Saquinavir / administration & dosage
  • Saquinavir / therapeutic use*

Substances

  • HIV Protease Inhibitors
  • Oligopeptides
  • Pyridines
  • Atazanavir Sulfate
  • Saquinavir
  • Ritonavir